Authors concluded that soft tissue malignancies (1076 cases), digestive tract cancers (931 cases), nervous system neoplasms (732 cases), cancer of unknown primary (CUP, 262 cases), and respiratory system cancers (207 cancers) are among the five most common types of malignancies affected by mutations in the KRAS gene [36]. This evidence concerns the gene KRAS and cancer.